TSmiR, miR-96 has been reported to inhibit pancreatic cancer cell proliferation, migration and invasion by 3′-UTR of Novel (nua) kinase family 1 (NUAK1), an oncogene in pancreatic cancer [75]. This evidence concerns the gene NUAK1 and familial pancreatic carcinoma.